Management of Clinical T1N0M0 Esophageal Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Endoscopic resection is a standard treatment for stage T1a esophageal cancer, with esophagectomy or radical radiation therapy (RT) performed for stage T1b lesions. This study aimed to compare treatment outcomes of each modality for clinical stage T1 esophageal cancer. Methods: In total, 179 patients with clinical T1N0M0- stage esophageal cancer treated from 2006 to 2016 were retrospectively evaluated. Sixty-two patients with clinical T1astage cancer underwent endoscopic resection. Among 117 patients with clinical T1b-stage cancer, 82 underwent esophagectomy, and 35 received chemoradiotherapy or RT. We compared overall survival (OS) and recurrence-free survival (RFS) rates for each treatment modality. Results: The median follow-up time was 32 months (range, 1 to 120 months). The 5-year OS and RFS rates for patients with stage T1a cancer receiving endoscopic resection were 100% and 85%, respectively. For patients with stage T1b, the 5-year OS and RFS rates were 78% and 77%, respectively, for the esophagectomy group; 80% and 44%, respectively, for the RT alone group; and 96% and 80%, respectively, for the chemoradiation group. The esophagectomy group showed significantly higher RFS than the RT alone group (p=0.04). There was no significant difference in RFS between the esophagectomy and chemoradiation groups (p=0.922). Grade 4 or higher treatment-related complications occurred in four patients who underwent esophagectomy. Conclusions: Endoscopic resection appeared to be an adequate treatment for patients with T1a-stage esophageal cancer. The multidisciplinary approach involving chemoradiation was comparable to esophagectomy in terms of survival outcome without serious complications for T1b-stage esophageal cancer.
Abstract
Background/Aims: Endoscopic resection is a standard treatment for stage T1a esophageal cancer, with esophagectomy or radical radiation therapy (RT) performed for stage T1b lesions. This study aimed to compare treatment outcomes of each modality for clinical stage T1 esophageal cancer. Methods: In total, 179 patients with clinical T1N0M0- stage esophageal cancer treated from 2006 to 2016 were retrospectively evaluated. Sixty-two patients with clinical T1astage cancer underwent endoscopic resection. Among 117 patients with clinical T1b-stage cancer, 82 underwent esophagectomy, and 35 received chemoradiotherapy or RT. We compared overall survival (OS) and recurrence-free survival (RFS) rates for each treatment modality. Results: The median follow-up time was 32 months (range, 1 to 120 months). The 5-year OS and RFS rates for patients with stage T1a cancer receiving endoscopic resection were 100% and 85%, respectively. For patients with stage T1b, the 5-year OS and RFS rates were 78% and 77%, respectively, for the esophagectomy group; 80% and 44%, respectively, for the RT alone group; and 96% and 80%, respectively, for the chemoradiation group. The esophagectomy group showed significantly higher RFS than the RT alone group (p=0.04). There was no significant difference in RFS between the esophagectomy and chemoradiation groups (p=0.922). Grade 4 or higher treatment-related complications occurred in four patients who underwent esophagectomy. Conclusions: Endoscopic resection appeared to be an adequate treatment for patients with T1a-stage esophageal cancer. The multidisciplinary approach involving chemoradiation was comparable to esophagectomy in terms of survival outcome without serious complications for T1b-stage esophageal cancer.
참고문헌 (16)
- Zeng Y, "Endoscopic treatment versus esophagectomy for early-stage esophageal cancer : a populationbased study using propensity score matching", J Gastrointest Surg, 21, pp.1977~1983 (2017)
- Pennathur A, "Esophagectomy for T1 esophageal cancer : outcomes in 100 patients and implications for endoscopic therapy", Ann Thorac Surg, 87, pp.1048~1054 (2009)
- Enzinger PC, "Esophageal cancer", N Engl J Med, 349, pp.2241~2252 (2003)
- Rice TW, "Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer", International Union Against Cancer Cancer Staging Manuals, 2010, pp.116, 3763~3773
- Wang S, "Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1esophageal cancer? A propensity score-based analysis", Surg Endosc, 32, pp.1441~1448 (2018)
- Rice TW, "Superficial adenocarcinoma of the esophagus", J Thorac Cardiovasc Surg, 122, pp.1077~1090 (2001)
- Pennathur A, "Surgical aspects of the patient with high-grade dysplasia", Semin Thorac Cardiovasc Surg, 17, pp.326~332 (2005)
- Cao C, "Definitive radiotherapy for cervical esophageal cancer", Head Neck, 37, pp.151~155 (2015)
- 이현직, "Treatment Strategy after Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma: A Single Institution Experience", Gut and Liver, 9(6), pp.714~719 (2015), 거트앤리버 소화기연관학회협의회
- Kim DJ, "Feasibility of a robotassisted thoracoscopic lymphadenectomy along the recurrent laryngeal nerves in radical esophagectomy for esophageal squamous carcinoma", Surg Endosc, 28, pp.1866~1873 (2014)
- Matsumoto S, "A comparison of surgery and radiation therapy for cT1 esophageal squamous cell carcinoma", Dis Esophagus, 24, pp.411~417 (2011)
- Herskovic A, "Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus", N Engl J Med, 326, pp.1593~1598 (1992)
- Nemoto K, "Radiation therapy for superficial esophageal cancer : a comparison of radiotherapy methods", Int J Radiat Oncol Biol Phys, 50, pp.639~644 (2001)
- Sasaki T, "Treatment outcomes of radiotherapy for patients with stage I esophageal cancer : a single institute experience", Am J Clin Oncol, 30, pp.514~519 (2007)
- Wani S, "Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer : a population-based study", Gastrointest Endosc, 79, pp.224~232 (2014)[DOI]
- Moreno AC, "Patterns of care and treatment outcomes of elderly patients with stage I esophageal cancer : analysis of the national cancer data base", J Thorac Oncol, 12, pp.1152~1160 (2017)